BRAF mutations are detected in ~7%–15% of all cancers, including hairy cell leukemia (79%–100%), melanomas (40%–70%), papillary thyroid cancers (45%), ovarian cancers (35%), and multiple myeloma (4%). This evidence concerns the gene BRAF and plasma cell myeloma.